The hydroxyl groups can be selectively substituted to control the solubility and the complex forming selectivity of the modified cyclodextrins (CDs). Among the methylated CDs only two well-defined compounds can be taken into consideration: dimethyl- and dimethyl-βCD (DIMEB and TRIMEB). In an aqueous solution of DIMEB the solubility of rather insoluble compounds and drugs like steroids, vitamin D3, lidocaine and hydrocortisone increases. In some cases their stability and bioavailability are also improved. On the other hand, the hydrolysis rate of carmofur, coumarins etc. is retarded by the methylated cyclodextrins with blocked hydroxyl groups. The drug solubilizing capacity of hydroxypropyl-βCD (HPBCD) is in most cases lower than that of DIMEB. The degree of substitution (DS) shows no remarkable effect on the solubilizing properties of HPBCD in the case of indomethacin, Dipiridamole etc., but in the case of Tolnaftate the solubility was enhanced by increasing the DS, other examples are show